Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Chemotherapy-related changes in cognitive functioning
Sanne B. Schagen, Jeffrey S. Wefel
European Journal of Cancer Supplements (2013) Vol. 11, Iss. 2, pp. 225-232
Open Access | Times Cited: 63

Showing 1-25 of 63 citing articles:

Cognitive impairment after cancer treatment: mechanisms, clinical characterization, and management
Ben Fleming, Paul Edison, Laura Kenny
BMJ (2023), pp. e071726-e071726
Closed Access | Times Cited: 42
Treatment of cognitive deficits in brain tumour patients: current status and future directions
Marijke B Coomans, Sophie D. van der Linden, Karin Gehring, et al.
Current Opinion in Oncology (2019) Vol. 31, Iss. 6, pp. 540-547
Open Access | Times Cited: 90
Chemotherapy and cognition: comprehensive review on doxorubicin-induced chemobrain
Sara Emad El-Agamy, Amal Kamal Abdel‐Aziz, Ahmed Esmat, et al.
Cancer Chemotherapy and Pharmacology (2019) Vol. 84, Iss. 1, pp. 1-14
Closed Access | Times Cited: 77
Nose-to-brain delivery of chrysin transfersomal and composite vesicles in doxorubicin-induced cognitive impairment in rats: Insights on formulation, oxidative stress and TLR4/NF-kB/NLRP3 pathways
Shaimaa S. Ibrahim, Omar G. Abo Elseoud, Mohamed H. Mohamedy, et al.
Neuropharmacology (2021) Vol. 197, pp. 108738-108738
Closed Access | Times Cited: 58
Neurological and vascular complications of primary and secondary brain tumours: EANO-ESMO Clinical Practice Guidelines for prophylaxis, diagnosis, treatment and follow-up
Patrick Roth, Andrea Pace, Émilie Le Rhun, et al.
Annals of Oncology (2020) Vol. 32, Iss. 2, pp. 171-182
Open Access | Times Cited: 61
Systematic review of cognitive sequelae of non-central nervous system cancer and cancer therapy
Noemí Cerulla, J. Blas Navarro, Núria de la Osa
Journal of Cancer Survivorship (2020) Vol. 14, Iss. 4, pp. 464-482
Closed Access | Times Cited: 54
Cognitive impairment following breast cancer treatments: an umbrella review
Giulia Oliva, Andreina Giustiniani, Laura Danesin, et al.
The Oncologist (2024) Vol. 29, Iss. 7, pp. e848-e863
Open Access | Times Cited: 7
Cognitive disability in adult patients with brain tumors
Faisal S. Ali, Maryam Hussain, Carolina Gutiérrez, et al.
Cancer Treatment Reviews (2018) Vol. 65, pp. 33-40
Closed Access | Times Cited: 57
Curcumin Administration Mitigates Cyclophosphamide-Induced Oxidative Damage and Restores Alteration of Enzymes Associated with Cognitive Function in Rats’ Brain
Seun F. Akomolafe, Tosin A. Olasehinde, Sunday I. Oyeleye, et al.
Neurotoxicity Research (2020) Vol. 38, Iss. 1, pp. 199-210
Closed Access | Times Cited: 41
Peroxisomes contribute to oxidative stress in neurons during doxorubicin-based chemotherapy
Jose F. Moruno-Manchon, Ndidi-Ese Uzor, Shelli R. Kesler, et al.
Molecular and Cellular Neuroscience (2017) Vol. 86, pp. 65-71
Open Access | Times Cited: 47
Quantitative Imaging Biomarkers of Damage to Critical Memory Regions Are Associated With Post–Radiation Therapy Memory Performance in Brain Tumor Patients
Kathryn R. Tringale, Tanya T. Nguyen, Roshan Karunamuni, et al.
International Journal of Radiation Oncology*Biology*Physics (2019) Vol. 105, Iss. 4, pp. 773-783
Open Access | Times Cited: 40
Late effects of cancer treatment: consequences for long-term brain cancer survivors
Montse Alemany, Roser Velasco, Marta Simó, et al.
Neuro-Oncology Practice (2020) Vol. 8, Iss. 1, pp. 18-30
Open Access | Times Cited: 36
A systematic review of rehabilitation programs for cognitive impairment related to breast cancer: Different programs at different times?
Marianne Merceur, Karen T. Reilly, I. Bonan, et al.
Annals of Physical and Rehabilitation Medicine (2024) Vol. 67, Iss. 5, pp. 101832-101832
Open Access | Times Cited: 4
Potential of Natural Phenolic Compounds against Doxorubicin-Induced Chemobrain: Biological and Molecular Mechanisms Involved
Simona Serini, Gabriella Calviello
Antioxidants (2024) Vol. 13, Iss. 4, pp. 486-486
Open Access | Times Cited: 4
Cognitive Decline in Glioblastoma (GB) Patients with Different Treatment Modalities and Insights on Untreated Cases
Keyvan Ghadimi, Imane Abbas, Alireza Karandish, et al.
Current Oncology (2025) Vol. 32, Iss. 3, pp. 152-152
Open Access
Protective effects of omega-3 against procarbazine-induced brain damage in the cerebellum and CA1 Hippocampus of male rats: a focus on oxidative stress mechanisms
Maryam Abolghasemi, Ali Shamsara, Masoumeh‎‏‏ Nozari, et al.
Metabolic Brain Disease (2025) Vol. 40, Iss. 3
Closed Access
Meta-analyses of executive function deficits in chemotherapy-treated rodent models
Weiye Chen, Ian N. Johnston
Neuroscience & Biobehavioral Reviews (2025), pp. 106131-106131
Open Access
Molecular Subtypes and Targeted Therapeutic Strategies in Small Cell Lung Cancer: Advances, Challenges, and Future Perspectives
Daoyuan Huang, Jingchao Wang, Li Chen, et al.
Molecules (2025) Vol. 30, Iss. 8, pp. 1731-1731
Open Access
The Effect of Nonpharmacological Interventions on Managing Symptom Clusters Among Cancer Patients
Winnie K.W. So, Bernard M. H. Law, Dorothy N.S. Chan, et al.
Cancer Nursing (2019) Vol. 43, Iss. 6, pp. E304-E327
Open Access | Times Cited: 32
Quality of Life and Role of Palliative and Supportive Care for Patients With Brain Metastases and Caregivers: A Review
Adela Wu, Gabriela D. Ruiz Colón, Michael Lim
Frontiers in Neurology (2022) Vol. 13
Open Access | Times Cited: 15
Neuropsychological Practice in the Oncology Setting
Kyle R. Noll, Mariana E. Bradshaw, Jennie L. Rexer, et al.
Archives of Clinical Neuropsychology (2017) Vol. 33, Iss. 3, pp. 344-353
Open Access | Times Cited: 26
Type of cancer treatment and cognitive symptoms in working cancer survivors: an 18-month follow-up study
Johanna K. Ehrenstein, Sander K. R. van Zon, Saskia F. A. Duijts, et al.
Journal of Cancer Survivorship (2020) Vol. 14, Iss. 2, pp. 158-167
Open Access | Times Cited: 21
Patient-reported neurocognitive function in adult survivors of childhood and adolescent osteosarcoma and Ewing sarcoma
Nina S. Kadan‐Lottick, Daniel J. Zheng, Mingjuan Wang, et al.
Journal of Cancer Survivorship (2022) Vol. 17, Iss. 4, pp. 1238-1250
Closed Access | Times Cited: 13
The Feasibility of Using Metacognitive Strategy Training to Improve Cognitive Performance and Neural Connectivity in Women with Chemotherapy-Induced Cognitive Impairment
Timothy Wolf, Meghan Doherty, Dorina Kallogjeri, et al.
Oncology (2016) Vol. 91, Iss. 3, pp. 143-152
Open Access | Times Cited: 22
Serum neurofilament light chain levels as biomarker of paclitaxel-induced cognitive impairment in patients with breast cancer: a prospective study
Andreas A. Argyriou, Sofia Karteri, Jordi Bruna, et al.
Supportive Care in Cancer (2021) Vol. 30, Iss. 2, pp. 1807-1814
Closed Access | Times Cited: 16
Page 1 - Next Page

Scroll to top